Clinical and Molecular Epidemiology of Extended-Spectrum β -Lactamase—Producing Escherichia coli as a Cause of Nosocomial Infection or Colonization …

J Rodríguez-Baño, MD Navarro… - Clinical infectious …, 2006 - academic.oup.com
… The epidemiology of these organisms as causes of nosocomial infection is poorly understood.
The aims of this study were to investigate the clinical and molecular epidemiology of …

[HTML][HTML] Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae

G De Angelis, P Del Giacomo, B Posteraro… - … journal of molecular …, 2020 - mdpi.com
… about the molecular mechanisms and epidemiology of β-lactamase-mediated β-lactam
resistance in Enterobacteriaceae, and their potential impact on clinical outcomes of β-lactam-…

The molecular and clinical epidemiology of Enterobacteriaceae-producing extended-spectrum β-lactamase in a tertiary care hospital

E d'Agata, L Venkataraman, P DeGirolami, L Weigel… - Journal of Infection, 1998 - Elsevier
Molecular epidemiology of an SHV-5 extended-spectrum fi-lactamase in Enterobacteriaceae
isolated from infants in a neonatal intensive care unit. Clin InfDis 1995; 21: 915-923. …

Extended-spectrum β-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options

G Peirano, JDD Pitout - Drugs, 2019 - Springer
… The aim of this article is to describe the molecular epidemiology (ie, the roles of mobile genetic
elements and high-risk clones) of Enterobacteriaceae with CTX-M β-lactamases (using E. …

Epidemiology of β-lactamase-producing pathogens

K Bush, PA Bradford - Clinical microbiology reviews, 2020 - Am Soc Microbiol
… -lactam antibiotics in various geographical locations. In this review, the epidemiology of
clinically relevant and widely dispersed β-lactamases is presented concerning present and past …

Clinical Features and Molecular Epidemiology of CMY-Type β-Lactamase–Producing Escherichia coli

HE Sidjabat, DL Paterson, ZA Qureshi… - Clinical infectious …, 2009 - academic.oup.com
β-lactamase is limited. Of the several groups of plasmid-mediated AmpC β-lactamases,
CMY-type β-lactamase … coli strains that produce CMY-type β-lactamase, and we collected clinical

Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan

Y Chong, H Yakushiji, Y Ito, T Kamimura - European journal of clinical …, 2011 - Springer
The detection rates of extended-spectrum β-lactamase (ESBL)-producing bacteria in Japan
are very low (∼5%) compared with those obtained worldwide. Further, the current trend of …

Clinical and molecular epidemiology of community-onset, extended-spectrum β-lactamase-producing Escherichia coli infections in Thailand: A case-case-control …

A Apisarnthanarak, P Kiratisin, P Saifon… - American journal of …, 2007 - Elsevier
… The primary objectives of this study were to identify the clinical risks and molecular epidemiology
(antimicrobial susceptibility patterns, transmission, and strain types) associated with CO…

[HTML][HTML] Clinical and Molecular Epidemiology of Community-Onset Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli over a 6 …

CI Kang, MK Cha, SH Kim, KS Ko… - … of Korean medical …, 2013 - synapse.koreamed.org
… We reviewed the medical records of individuals diagnosed with E. coli bacteremia from
January … Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the …

Characterization and molecular epidemiology of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University hospital

S Dahmen, D Bettaieb, W Mansour… - Microbial drug …, 2010 - liebertpub.com
… Brisse FXWeill 2010Molecular epidemiology of extended-spectrum b-lactamase-producing
Klebsiella … Molecular epidemiology of extended-spectrum b-lactamase-producing Klebsiella …